Moolec Science (NASDAQ: MLEC) CEO details option and RSU awards

Rhea-AI Filing Summary

Moolec Science SA filed an initial ownership report for Chief Executive Officer Alejandro Carlos Antalich, detailing his equity-based awards in ordinary shares. The filing lists share options for 3,334, 3,333 and 3,333 underlying shares at an exercise price of $7.1400, expiring between 2031 and 2033.

It also shows restricted share units linked to 6,667 and 6,666 underlying ordinary shares at exercise prices of $14.2800 and $28.5600, expiring on February 6, 2031. These entries describe existing awards and do not reflect new open-market purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Antalich Raibar Alejandro Carlos

(Last) (First) (Middle)

AV AMERICO RICALDONI 2527 APT 302

(Street)

MONTEVIDEO 11600

(City) (State) (Zip)

URUGUAY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/06/2026

3. Issuer Name and Ticker or Trading Symbol
Moolec Science SA [ MLEC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ordinary shares	02/06/2026	06/30/2031	Share Option	3,334	$7.14	D
Ordinary shares	06/30/2027	06/30/2032	Share Option	3,333	$7.14	D
Ordinary shares	06/30/2028	06/30/2033	Share Option	3,333	$7.14	D
Ordinary shares	02/06/2026	02/06/2031	Restricted Share Unit	6,667	$14.28	D
Ordinary shares	02/06/2026	02/06/2031	Restricted Share Unit	6,666	$28.56	D

Explanation of Responses:

	/s/ Alejandro Carlos Antalich	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Moolec Science (MLEC) CEO report in this Form 3?

The Moolec Science CEO reports his existing equity awards, including share options and restricted share units tied to ordinary shares. This Form 3 establishes his initial beneficial ownership position as a company insider, without showing any new market purchases or sales.

Did the Moolec Science (MLEC) CEO buy or sell shares in this filing?

No, the Form 3 does not show any share purchases or sales. It only lists existing equity awards such as options and restricted share units, categorized as holdings, with no buy or sell transaction codes or share amounts disclosed as traded.

What option awards for MLEC shares are disclosed for the CEO?

The CEO holds share options over 3,334, 3,333 and 3,333 underlying ordinary shares, each with an exercise price of $7.1400. These options have expiration dates ranging from June 30, 2031 through June 30, 2033, documenting long-dated incentive awards.

What restricted share units in Moolec Science (MLEC) are reported?

The filing lists restricted share units over 6,667 and 6,666 underlying ordinary shares, with exercise prices of $14.2800 and $28.5600. Both RSU awards carry an expiration date of February 6, 2031, illustrating additional long-term equity incentives.

Why is this Moolec Science (MLEC) Form 3 important for investors?

This Form 3 clarifies how the CEO is aligned with shareholders through equity-based compensation. By disclosing specific option and RSU grants, investors can see the scale and structure of his potential ownership, even though no immediate trading activity is reported here.